Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Created material boosts hair growth and kills bacteria for wound healing.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Minoxidil and finasteride treat hair loss; more research needed for other options.

HFMs can help study hair growth and test potential hair growth drugs.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Nonionic liposomes are the best for delivering genes to skin cells.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.